HUT65736A - Process for producing 2-saccharinylmethyl-aryl and aryloxy acetates and pharmaceutical preparations containing them - Google Patents

Process for producing 2-saccharinylmethyl-aryl and aryloxy acetates and pharmaceutical preparations containing them

Info

Publication number
HUT65736A
HUT65736A HU9204166A HU9204166A HUT65736A HU T65736 A HUT65736 A HU T65736A HU 9204166 A HU9204166 A HU 9204166A HU 9204166 A HU9204166 A HU 9204166A HU T65736 A HUT65736 A HU T65736A
Authority
HU
Hungary
Prior art keywords
saccharinylmethyl
aryl
producing
pharmaceutical preparations
preparations containing
Prior art date
Application number
HU9204166A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9204166D0 (en
Inventor
Richard Paul Dunlap
Lee Hamilton Latimer
Original Assignee
Sterling Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Winthrop Inc filed Critical Sterling Winthrop Inc
Publication of HU9204166D0 publication Critical patent/HU9204166D0/hu
Publication of HUT65736A publication Critical patent/HUT65736A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU9204166A 1991-12-30 1992-12-30 Process for producing 2-saccharinylmethyl-aryl and aryloxy acetates and pharmaceutical preparations containing them HUT65736A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81574091A 1991-12-30 1991-12-30

Publications (2)

Publication Number Publication Date
HU9204166D0 HU9204166D0 (en) 1993-04-28
HUT65736A true HUT65736A (en) 1994-07-28

Family

ID=25218721

Family Applications (2)

Application Number Title Priority Date Filing Date
HU9204166A HUT65736A (en) 1991-12-30 1992-12-30 Process for producing 2-saccharinylmethyl-aryl and aryloxy acetates and pharmaceutical preparations containing them
HU95P/P00619P HU211625A9 (en) 1991-12-30 1995-06-30 Novel 2-saccharinylmethyl aryl and aryloxy acetates useful as proteolytic enzyme inhibitors and compositions and method of use thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU95P/P00619P HU211625A9 (en) 1991-12-30 1995-06-30 Novel 2-saccharinylmethyl aryl and aryloxy acetates useful as proteolytic enzyme inhibitors and compositions and method of use thereof

Country Status (17)

Country Link
US (3) US5385923A (en, 2012)
EP (1) EP0550112A1 (en, 2012)
JP (1) JPH05255286A (en, 2012)
AU (1) AU651746B2 (en, 2012)
CA (1) CA2086348A1 (en, 2012)
CZ (1) CZ386992A3 (en, 2012)
FI (1) FI925946L (en, 2012)
HU (2) HUT65736A (en, 2012)
IL (1) IL104259A (en, 2012)
MX (1) MX9207274A (en, 2012)
MY (1) MY108926A (en, 2012)
NO (1) NO303446B1 (en, 2012)
NZ (1) NZ245586A (en, 2012)
PH (1) PH30411A (en, 2012)
RU (1) RU2081871C1 (en, 2012)
SG (1) SG48025A1 (en, 2012)
TW (1) TW226016B (en, 2012)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380737A (en) * 1989-05-04 1995-01-10 Sterling Winthrop Inc. Saccharin derivative proteolytic enzyme inhibitors
US5306818A (en) * 1990-11-01 1994-04-26 Sterling Winthrop Inc. Tetrahydro 2-saccharinylmerthyl aryl carboxylates
DE19533643A1 (de) * 1995-09-12 1997-03-13 Nycomed Arzneimittel Gmbh Neue cyclische Derivate von Benzolsulfonamiden
DE19748470A1 (de) * 1997-11-03 1999-05-06 Hoechst Schering Agrevo Gmbh Carbamoylphenylsulfonylharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und Pflanzenwachstumsregulatoren
US20090053221A1 (en) * 2006-01-17 2009-02-26 Cheung Nai-Kong V Immune response enhancing glucan
AU2010266018B2 (en) 2009-06-25 2014-01-09 Alkermes Pharma Ireland Limited Heterocyclic compounds for the treatment of neurological and psychological disorders
CA2937222C (en) 2009-06-25 2019-06-04 Alkermes Pharma Ireland Limited Prodrugs of nh-acidic compounds
AU2010339689B2 (en) * 2010-01-07 2015-02-19 Alkermes Pharma Ireland Limited Quaternary ammonium salt prodrugs
WO2011163594A2 (en) 2010-06-24 2011-12-29 Alkermes, Inc. Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
HRP20161549T1 (hr) 2011-03-18 2016-12-30 Alkermes Pharma Ireland Limited Injektabilni farmaceutski pripravci koji sadrže antipsihotik koji je netopljiv u vodi, sorbitan laurat i polisorbat 20
EP2790734B1 (en) 2011-12-15 2019-02-20 Alkermes Pharma Ireland Limited Prodrugs of secondary amine compounds
US9999670B2 (en) 2012-03-19 2018-06-19 Alkermes Pharma Ireland Limited Pharmaceutical compositions comprising benzyl alcohol
NZ630643A (en) 2012-03-19 2017-08-25 Alkermes Pharma Ireland Ltd Pharmaceutical compositions comprising fatty acid esters
AU2013235523B9 (en) 2012-03-19 2018-01-04 Alkermes Pharma Ireland Limited Pharmaceutical compositions comprising glycerol esters
ES2792149T3 (es) 2012-09-19 2020-11-10 Alkermes Pharma Ireland Ltd Composiciones farmacéuticas que tienen estabilidad de almacenamiento mejorada
CA2934938C (en) 2013-12-31 2019-04-30 Saint-Gobain Abrasives, Inc. Abrasive article including shaped abrasive particles
US20150253127A1 (en) * 2014-03-04 2015-09-10 Honeywell Asca Inc. Thickness Determination of Web Product by Mid-infrared Wavelength Scanning Interferometry
JP6524110B2 (ja) 2014-03-20 2019-06-05 アルカームス ファーマ アイルランド リミテッド 注射速度が増大したアリピプラゾール調合物
US10346168B2 (en) 2015-06-26 2019-07-09 Microsoft Technology Licensing, Llc Decoupled processor instruction window and operand buffer
AU2019230014B2 (en) 2018-03-05 2024-11-28 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3002884A (en) * 1959-04-15 1961-10-03 Rohm & Haas Horticultural process with n-halomethyl-1,2-benzisothiazolin - 3 - one-1,1-dioxides for controlling fungus diseases
US3314960A (en) * 1964-08-25 1967-04-18 American Home Prod Benzisothiazol glutarimides
FR1451417A (fr) * 1965-07-15 1966-01-07 Roussel Uclaf Nouveaux esters d'acides cycliques et leur procédé de préparation
JPS4835457A (en, 2012) * 1971-09-02 1973-05-24
US4195023A (en) * 1975-08-20 1980-03-25 Merck & Co., Inc. 2-(2-Furoyl)1,2-benzisothiazole-3-one, 2-(2-furoyl) saccharin, and 2-(2-thenoyl) saccharin
US4276298A (en) * 1978-03-24 1981-06-30 Merck & Co., Inc. 2-Aryl-1,2-benzisothiazolinone-1,1-dioxides and their use as selective protease inhibitors
US4263393A (en) * 1979-09-06 1981-04-21 Eastman Kodak Company Novel electron donor precursors and photographic element containing them
US4350752A (en) * 1980-12-29 1982-09-21 Eastman Kodak Company Photographic elements and film units containing imidomethyl blocked photographic reagents
US4363865A (en) * 1981-03-04 1982-12-14 Eastman Kodak Company Imido methyl blocked photographic dyes and dye releasing compounds
US4410618A (en) * 1982-06-11 1983-10-18 Eastman Kodak Company Blocked photographic reagents
US4547371A (en) * 1983-04-18 1985-10-15 Merck & Co., Inc. Substituted cephalosporin sulfones as anti-inflammatory and anti-degenerative agents
US4623645A (en) * 1983-04-18 1986-11-18 Merck & Co., Inc. Substituted cephalosporin sulfoxides as anti-inflammatory and antidegenerative agents
US4659855A (en) * 1983-05-09 1987-04-21 Georgia Tech Research Corporation Aryl sulfonyl fluoride compounds
DE3617976A1 (de) * 1986-05-28 1988-01-14 Alter Sa 1,4-dihydropyridin, verfahren zu dessen herstellung und dessen verwendung in antithrombotischen medikamenten
EP0253029A1 (en) * 1986-07-10 1988-01-20 Keng-Ben Wang A distilled drinking water fountain
AU637614B2 (en) * 1989-05-04 1993-06-03 Sanofi Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof
US5128339A (en) * 1990-11-01 1992-07-07 Sterling Winthrop Inc. Proteolytic enzyme inhibition method
FR2659327A1 (fr) * 1990-03-08 1991-09-13 Centre Nat Rech Scient Derives du benzisothiazolinone-1-dioxyde, utilisables comme inhibiteurs des elastases.
AU642537B2 (en) * 1990-11-01 1993-10-21 Sanofi 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5279758A (en) * 1991-10-22 1994-01-18 The Clorox Company Thickened aqueous cleaning compositions
AU656027B2 (en) * 1991-11-15 1995-01-19 Sanofi Saccharin derivative proteolytic enzime inhibitors
AU653279B2 (en) * 1991-12-30 1994-09-22 Sanofi Novel 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
JPH07200419A (ja) * 1993-12-28 1995-08-04 Nec Corp バスインタフェース装置
DE4420271B4 (de) * 1994-06-10 2007-09-27 Robert Bosch Gmbh Zündspulensatz für eine Mehrzylinder-Brennkraftmaschine

Also Published As

Publication number Publication date
MX9207274A (es) 1993-06-01
CZ386992A3 (en) 1993-09-15
NZ245586A (en) 1994-11-25
PH30411A (en) 1997-05-09
EP0550112A1 (en) 1993-07-07
NO303446B1 (no) 1998-07-13
CA2086348A1 (en) 1993-07-01
HU211625A9 (en) 1995-12-28
IL104259A (en) 1997-09-30
RU2081871C1 (ru) 1997-06-20
NO925041L (no) 1993-07-01
NO925041D0 (no) 1992-12-30
FI925946A7 (fi) 1993-07-01
IL104259A0 (en) 1993-05-13
FI925946L (fi) 1993-07-01
FI925946A0 (fi) 1992-12-30
HU9204166D0 (en) 1993-04-28
AU2966992A (en) 1993-07-01
US5489604A (en) 1996-02-06
US5385923A (en) 1995-01-31
AU651746B2 (en) 1994-07-28
US5783589A (en) 1998-07-21
TW226016B (en, 2012) 1994-07-01
SG48025A1 (en) 1998-04-17
MY108926A (en) 1996-11-30
JPH05255286A (ja) 1993-10-05

Similar Documents

Publication Publication Date Title
HUT65204A (en) Process for producing pyrazolopyrimidine and -triazine derivatives and pharmaceutical preparations containing them
HUT65736A (en) Process for producing 2-saccharinylmethyl-aryl and aryloxy acetates and pharmaceutical preparations containing them
HUT65734A (en) Process for producing asymmetric substituated xanthine derivatives and pharmaceutical preparations containing them
HU9400413D0 (en) Imidazoly-alcenoic acids, pharmaceutical compositions containing them, and process for producing them
HU9301054D0 (en) Method for producing cyclopeptides and pharmaceutical preparatives containing them
HU903281D0 (en) Process for producing 2-hydroxy-n-propyl-amines and containing them pharmaceutical preparatives
HU894124D0 (en) Process for producing peptides and pharmaceutical preparatives containing these peptides
HU913450D0 (en) Process for the production of cyclopeptides and medical preparations containing them
HU9303603D0 (en) Process for producing isoquinoline derivatives and pharmaceutical preparations containing them
HU914060D0 (en) Medical preparation and process for its production
LTIP709A (en) Sbstituted corticoid-17-alkylcarbonates, process for preparing thereof and pharmaceutical preparations
HU913430D0 (en) 2-substituted-methyl-aryl-carboxylates, medical preparations containing them and process for their production
HUT65619A (en) Process for producing bisheterocyclic compounds and pharmaceutical preparations containing them
GB9120628D0 (en) Pyrrolobenzoxazine derivatives and process for preparation thereof
HUT53802A (en) Process for producing pharmaceutical preparations containing piperidino-alkanole-derivatives
LTIP760A (en) Novel thienothiazine derivatives, process for preparing thereof and pharmaceutical preparations
HUT65300A (en) Process for producing benzimidazole derivatives and pharmaceutical preparations containing them
HU912213D0 (en) Process for the production of amino-diol derivatives and medical preparations containing them
HUT65224A (en) Process for producing alkoxymethylsubstituted pyridonbiphenyl derivatives and pharmaceutical preparations containing them
HUT65633A (en) Process for producing tetrazole derivatives and pharmaceutical preparations containing them
HUT65405A (en) Process for producing 1-heteroarylazetidines and pyrrolidines and pharmaceutical preparations containing them
HUT51605A (en) Process for producing substituted 3-amino-sydnonimines and pharmaceutical preparations containing these compounds
HU9200230D0 (en) Process for the production of 3-amino-sidnonimine derivatives and medical preparations containing them
HUT65452A (en) Process for producing spiro-oxindole derivatives and pharmaceutical preparations containing them
GB8804337D0 (en) Acetate product & process

Legal Events

Date Code Title Description
DGB9 Succession in title of applicant

Owner name: SANOFI, FR

DFC4 Cancellation of temporary protection due to refusal